Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer

Authors: Bookman, Michael A | Gynecologic Oncology | October 1, 2023 | PubMed abstract

Explore all publications

Back To Top